Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Sanara MedTech (SMTI) over the last 4 years, with Q3 2025 value amounting to $228001.0.

  • Sanara MedTech's Other Accumulated Expenses fell 8804.12% to $228001.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $228001.0, marking a year-over-year decrease of 8804.12%. This contributed to the annual value of $1.1 million for FY2023, which is 540.73% down from last year.
  • Per Sanara MedTech's latest filing, its Other Accumulated Expenses stood at $228001.0 for Q3 2025, which was down 8804.12% from $39659.0 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Other Accumulated Expenses ranged from a high of $1.9 million in Q3 2024 and a low of $39659.0 during Q2 2025
  • For the 4-year period, Sanara MedTech's Other Accumulated Expenses averaged around $888853.3, with its median value being $989744.0 (2023).
  • As far as peak fluctuations go, Sanara MedTech's Other Accumulated Expenses surged by 9065.5% in 2024, and later tumbled by 9634.66% in 2025.
  • Sanara MedTech's Other Accumulated Expenses (Quarter) stood at $1.2 million in 2022, then fell by 5.41% to $1.1 million in 2023, then skyrocketed by 73.32% to $1.9 million in 2024, then crashed by 88.04% to $228001.0 in 2025.
  • Its Other Accumulated Expenses was $228001.0 in Q3 2025, compared to $39659.0 in Q2 2025 and $1.9 million in Q3 2024.